Mithra Pharmaceuticals SA (MITRA.BR)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|47||Non-Executive Chairman of the Board - Representing BDS Management BVBA|
|Chief Executive Officer, Executive Director - Representative of YIMA SPRL|
|2017||Chief Financial Officer|
- BRIEF-Mithra Pharmaceuticals Announces Completion Of Estelle Cycles In Phase III Contraception Studies
- BRIEF-Mithra Pharmaceuticals And Mayne Pharma's Vaginal Contraceptive Ring Accepted For Filing By FDA
- BRIEF-Mithra And Alvogen Sign LSA For Vaginal Contraception Ring In Russia
- BRIEF-Mithra Analysis Across A Range Of Parameters Points To Limited Hemostatic Impact For Estelle
- BRIEF-Mithra Pharmaceuticals FY Net Loss At 35.0 Million Euros